There still play needs to be a pivotal phase 3 trial. If i am remembering it correctly, The protocol has been submitted and the fda asked for a meeting to discuss this it which still has not occurred therefore no enrollment in the phase 3 trial yet. Approval or a way off.
All IMR(in my recollection)